BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 81 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $524,000 | +2.7% | 50,000 | 0.0% | 0.14% | +191.7% |
Q4 2022 | $510,000 | +1.4% | 50,000 | 0.0% | 0.05% | -46.1% |
Q3 2022 | $503,000 | 0.0% | 50,000 | 0.0% | 0.09% | +11.2% |
Q2 2022 | $503,000 | +0.8% | 50,000 | 0.0% | 0.08% | +116.2% |
Q1 2022 | $499,000 | -0.2% | 50,000 | 0.0% | 0.04% | +19.4% |
Q4 2021 | $500,000 | – | 50,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIFTH LANE CAPITAL, LP | 30,000 | $1,030,000 | 0.65% |
Wealthspring Capital LLC | 243,391 | $2,423,000 | 0.46% |
Spartan Fund Management Inc. | 150,000 | $1,484,000 | 0.31% |
HGC Investment Management Inc. | 1,000,000 | $10,020,000 | 0.31% |
Atalaya Capital Management LP | 250,000 | $2,518,000 | 0.30% |
Schechter Investment Advisors, LLC | 110,221 | $1,090,000 | 0.11% |
Bracebridge Capital, LLC | 50,000 | $503,000 | 0.08% |
Sage Mountain Advisors LLC | 25,610 | $253,000 | 0.04% |
Calamos Advisors LLC | 1,000,000 | $10,070,000 | 0.04% |
LMR Partners LLP | 250,000 | $2,515,000 | 0.04% |